Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hricak

Showing results (371-380 of 565) with videos related to

Pageof 57
Sort By:
American Family Physician|March 30, 2001
Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendationsG D Grossfeld, J S Wolf, M S Litwan, et al.
JCO Clinical Cancer Informatics|September 9, 2022
Programmatic Implementation of a Custom Subspecialized Oncologic Imaging Workflow Manager at a Tertiary Cancer CenterAnton S Becker, Jeeban P Das, Sungmin Woo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastasesChristopher C Riedl, Timothy Akhurst, Steven Larson, et al.
BJU International|January 18, 2007
Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imagingFergus V Coakley, Irene Chen, Aliya Qayyum, et al.
The Journal of Urology|December 1, 1986
Assessment of renal preservation by phosphorus-31 magnetic resonance spectroscopy: in vivo normothermic blood perfusionP N Bretan, D B Vigneron, H Hricak, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 1993
Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factorsH Hricak, J M Quivey, Z Campos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2021
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with <sup>18</sup>F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort StudyAndreas G Wibmer, Michael J Morris, Mithat Gonen, et al.
Radiology|September 1, 1988
Complete and partial ureteral obstruction: evaluation of renal effects with P-31 MR spectroscopy and Tc-DMSA scintigraphyD B Vigneron, A A Tzika, H Hricak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imagingKonstantin Dobrenkov, Malgorzata Olszewska, Yury Likar, et al.
The Journal of Urology|January 1, 1987
Assessment of clinical renal preservation by phosphorus-31 magnetic resonance spectroscopyP N Bretan, D B Vigneron, H Hricak, et al.
Pageof 57

Showing results (371-380 of 565) with videos related to

Sort By:
Pageof 57
American Family Physician|March 30, 2001
Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendationsG D Grossfeld, J S Wolf, M S Litwan, et al.
JCO Clinical Cancer Informatics|September 9, 2022
Programmatic Implementation of a Custom Subspecialized Oncologic Imaging Workflow Manager at a Tertiary Cancer CenterAnton S Becker, Jeeban P Das, Sungmin Woo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastasesChristopher C Riedl, Timothy Akhurst, Steven Larson, et al.
BJU International|January 18, 2007
Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imagingFergus V Coakley, Irene Chen, Aliya Qayyum, et al.
The Journal of Urology|December 1, 1986
Assessment of renal preservation by phosphorus-31 magnetic resonance spectroscopy: in vivo normothermic blood perfusionP N Bretan, D B Vigneron, H Hricak, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 1993
Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factorsH Hricak, J M Quivey, Z Campos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2021
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with <sup>18</sup>F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort StudyAndreas G Wibmer, Michael J Morris, Mithat Gonen, et al.
Radiology|September 1, 1988
Complete and partial ureteral obstruction: evaluation of renal effects with P-31 MR spectroscopy and Tc-DMSA scintigraphyD B Vigneron, A A Tzika, H Hricak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imagingKonstantin Dobrenkov, Malgorzata Olszewska, Yury Likar, et al.
The Journal of Urology|January 1, 1987
Assessment of clinical renal preservation by phosphorus-31 magnetic resonance spectroscopyP N Bretan, D B Vigneron, H Hricak, et al.
Pageof 57